We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Observation |

Idiopathic Inflammatory Myopathy Treated With High-Dose Immunoablative Cyclophosphamide—A Long-term Follow-up Study

Arash H. Lahouti, MD1; Robert A. Brodsky, MD2; Lisa Christopher-Stine, MD, MPH1
[+] Author Affiliations
1Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland
2Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
JAMA Neurol. 2015;72(10):1205-1206. doi:10.1001/jamaneurol.2015.1425.
Text Size: A A A
Published online


This long-term case report describes a woman with idiopathic inflammatory myopathy treated with high-dose immunoablative cyclophosphamide.

To our knowledge, this is the first report of the use of high-dose immunoablative cyclophosphamide (HiCy) therapy in the absence of stem cell rescue in patients with idiopathic inflammatory myopathy.

Article InformationCorresponding Author: Lisa Christopher-Stine, MD, MPH, Division of Rheumatology, Johns Hopkins University School of Medicine, 5200 Eastern Ave, MFL Center Tower, Ste 4500, Baltimore, MD 21224 (lchrist4@jhmi.edu).

Conflict of Interest Disclosures: Dr Christopher-Stine reports serving on the advisory board; receiving honoraria from Novartis, Mallinckrodt, Walgreens, and Medimmune; and having membership in the advisory board of Idera. She has intellectual property rights in connection with Inova Diagnostics. No other disclosures were reported.

Funding/Support: This study was supported by the Huayi and Siuling Zhang Discovery Fund.

Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Figures in this Article

First Page Preview

View Large
First page PDF preview


Place holder to copy figure label and caption
T2 Short Tau Inversion Recovery Magnetic Resonance Image of the Thigh Muscles

A, Eight months before high-dose immunoablative cyclophosphamide (HiCy) therapy, significant muscle edema in posterior and lateral compartments of both thighs is evident. B, Twenty-one months after HiCy therapy, the muscles of the posterior and medial compartments have been largely replaced by adipose tissue/fibrosis, but there is no evidence of acute inflammation.

Graphic Jump Location




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles